Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 | 38067234 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 38058035 | PubTator, text mining | PubMed |
| Lysine deserts and cullin-RING ligase receptors: Navigating untrodden paths in proteostasis. | iScience | 2023 | 38026164 | PubTator, text mining | PubMed |
| SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. | Front Immunol | 2023 | 38022642 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| ELOA3: A primate-specific RNA polymerase II elongation factor encoded by a tandem repeat gene cluster. | Sci Adv | 2023 | 37992162 | PubTator, text mining | PubMed |
| Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37981648 | PubTator, text mining | PubMed |
| ReGeNNe: genetic pathway-based deep neural network using canonical correlation regularizer for disease prediction. | Bioinformatics | 2023 | 37963055 | PubTator, text mining | PubMed |
| mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy. | Virchows Arch | 2023 | 37938323 | PubTator, text mining | PubMed |
| Structure of the transcribing RNA polymerase II-Elongin complex. | Nat Struct Mol Biol | 2023 | 37932450 | PubTator, text mining | PubMed |
| An Overview of Renal Cell Carcinoma Hallmarks, Drug Resistance, and Adjuvant Therapies. | Cancer Diagn Progn | 2023 | 37927802 | PubTator, text mining | PubMed |
| Mammalian Genomic Manipulation with Orthogonal Bxb1 DNA Recombinase Sites for the Functional Characterization of Protein Variants. | ACS Synth Biol | 2023 | 37922210 | PubTator, text mining | PubMed |
| Genetically Encoded Biosensors for the Fluorescence Detection of O2 and Reactive O2 Species. | Sensors (Basel) | 2023 | 37896609 | PubTator, text mining | PubMed |
| Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma. | Curr Oncol | 2023 | 37887570 | PubTator, text mining | PubMed |
| Molecular basis for C-degron recognition by CRL2APPBP2 ubiquitin ligase. | Proc Natl Acad Sci U S A | 2023 | 37844242 | Swiss-Prot, curated | PubMed |
| Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37827692 | PubTator, text mining | PubMed |
| USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A. | Cell Death Differ | 2023 | 37816999 | PubTator, text mining | PubMed |
| Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2. | Nat Commun | 2023 | 37816714 | Swiss-Prot, curated | PubMed |
| Rational Screening for Cooperativity in Small-Molecule Inducers of Protein-Protein Associations. | J Am Chem Soc | 2023 | 37816014 | PubTator, text mining | PubMed |
| The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation. | bioRxiv | 2023 | 37808699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=6